Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Case Western Reserve University uncovers genetic basis for some birth defects

Case Western Reserve University uncovers genetic basis for some birth defects

November 11, 2008

A multidisciplinary research team at Case Western Reserve University led by Gary Landreth, Ph.D., a professor in the School of Medicine's Department of Neurosciences, has uncovered a common genetic pathway for a number of birth defects that affect the development of the heart and head. Abnormal development of the jaw, palate, brain and heart are relatively common congenital defects and frequently arise due to genetic errors that affect a key developmental pathway.

The research, titled "Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development" is published in the November 10 issue of the Proceedings of the National Academy of Sciences of the United States of America.




Landreth, also the senior author of the study, developed a mouse model of these disorders by removing a gene central to this developmental pathway, called ERK2. He, together with Dr. William Snider at the University of North Carolina, discovered that the mice missing the gene for ERK2 in neural crest cells had developmental defects resembling those of human patients with a deletion that includes this gene. The patients have features that are similar to DiGeorge syndrome, which is associated with cardiac and palate defects. Interestingly, the ERK2 gene is central to a well-known pathway already associated with a different distinct group of cardiac and craniofacial syndromes that include Noonan, Costello, Cardiofaciocutaneous syndrome, and LEOPARD syndrome.

Landreth enlisted the help of Michiko Watanabe, Ph.D., professor of Pediatrics at Case Western Reserve University School of Medicine to look at the mouse hearts. She and her team found that they had characteristic heart defects resembling those seen in the patients with ERK2 deletions.

"Given Dr. Watanabe's findings, we determined that we had in fact developed animal models that mimicked the human deletion syndrome," said Landreth. "This work sheds light on how these developmental errors occur."

Remarkably, Dr. Sulagna Saitta, a human geneticist at Children's Hospital of Philadelphia had identified children who had comparable heart defects as well as subtle facial differences. These children were all missing a very small region of chromosome 22 that contained the ERK2 gene.

Saitta agreed that the similarity in the anatomic structures affected in the mice and those in the patients who have lost one copy of this gene suggest that ERK2 and its pathway members are essential for normal development and might lead to these birth defects. These findings link together several distinct syndromes that are each characterized by cardiac and craniofacial abnormalities and show that they can result from perturbations of the ERK cascade.

Landreth and his team will take these findings back to the lab and find out exactly why cells need ERK2 during embryogenesis.



Case Western Reserve University



Related Genetic Pathway Current Events and Genetic Pathway News Articles Genetic Pathway Current Events and Genetic Pathway News RSS Genetic Pathway Current Events and Genetic Pathway News RSS
UC San Diego researchers reverse pulmonary arterial hypertension in mouse models
Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.

Diabetes drug kills cancer stem cells in combination treatment in mice
In a one-two punch, a familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in the September 14 online first edition of Cancer Research, a journal of the American Association for Cancer Research.

Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis
A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS).

Genetic pathway responsible for link between body clock disturbance and worsening arthritis
The genes that regulate human circadian rhythm, or 'the body clock', are significantly disturbed in individuals with arthritis.

Penn Medicine, CHOP Researchers Demonstrate First Common Genetic Risk Factors for Autism
Researchers have made an important step forward in understanding the complex genetic structure of autism spectrum disorders.

'Autoantibodies' may be created in response to bacterial DNA
Autoimmune diseases have long been regarded as illnesses in which the immune system creates autoantibodies to attack the body itself.

Case Western Reserve research finds that the lack of specific gene plays role in autism
It is estimated that three to six out of every 1,000 children in the United States have autism - and the number of diagnosed cases is rising.

New genetic model predicts plant flowering in different environments
It has been known for some time that plants respond to environmental cues that guide their flowering. Chief among these signals are light, temperature and vernalization, when flowering is promoted by prolonged exposure to cold temperatures.

Research shows cell's inactive state is critical for effectiveness of cancer treatment
A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing.

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer
A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.
More Genetic Pathway Current Events and Genetic Pathway News Articles
  2nd Workshop on Computation of Biochemical Pathways and Genetic Networks
by C. van Gend, U. Kummer R. Gauges (Author)

The postgenomic era (as it is often called) aims at an increasing understanding of the complex biochemical network which is present in each cell, rather than at studying individual functions of specific enzymes and specific genes. This is a very ambitious goal. The 2nd Workshop on Computation of Biochemical Pathways and Genetic Networks will focus on the current state of research in this area at different levels of abstraction. Bringing together researchers with different backgrounds will enrich discussions on the best methods, as well as on the difficulties and limits imposed by the complexity of the problem.

DNA Health Test Kit

DNA Health Test Kit
by Pathway Genomics

Take the Health Test from Pathway Genomics to discover your Genetic Risk for 90+ Health Conditions. What is Tested: 1) Risk Markers for Disease: Prostate Cancer, Breast Cancer & Other Cancers, Cardiovascular Diseases, Rheumatoid Arthritis, Type 1 & 2 Diabetes, and More; 2) Disease Carrier Status: Tay Sachs, Cystic Fibrosis, Celiac Disease, Familial Dysautonomia, and More; 3) Drug Responses & Adverse Reactions: Genetic Interactions with commonly used medications including: Coumadin, Warfarin, Prozac, Zoloft, Paxil, and More; 4) Personal Traits: Identify your unique genetic traits such as freckling, baldness, alcohol flush, pain sensitivity, athletic muscle performance, and More.

  3rd Workshop on Computation of Biochemical Pathways and Genetic Networks
by Ursula Kummer, Jürgen Pahle, Ursula Rost Ralph Gauges (Author)



4th Workshop on Computation of Biochemical Pathways and Genetic Networks

4th Workshop on Computation of Biochemical Pathways and Genetic Networks
by J. Pahle, I. Surovtsova, J. Zobeley U. Kummer (Author)



  Workshop on Computation of Biochemical Pathways and Genetic Networks
by European Media Laboratory (Author)



  5th Workshop on Computation of Biochemical Pathways and Genetic Networks - A BioSim Event
by Ursula Kummer, Jürgen Pahle, Paul Miki Willy Ralph Gauges (Author)



Genetic variants in estrogen signaling pathways: Significance to cardiovascular physiology and pathophysiology

Genetic variants in estrogen signaling pathways: Significance to cardiovascular physiology and pathophysiology
by Gemma Figtree (Author)

Estrogen has a number of important beneficial effects in the cardiovascular system. We hypothesized that genetic variants in the estrogen receptor alpha (ERalpha) gene may cause variable sensitivity to the hormone and influence an individual?s risk of cardiovascular disease, along with other estrogen-sensitive phenotypes. This work explores the role of ERalpha in the mediation of the atheroprotective effects of estrogen and identifies regulatory regions in the ERalpha gene important in cardiovascular tissue. It identifies novel genetic variants in these regions and examines their effect on expression of the receptor in vitro, and their association with estrogen sensitive phenotypes in different study populations. The identification of genetic variations associated with...

  The De Novo Pyrimidine Biosynthetic Pathway of Bacillus Subtilis: I. Carbamyl Phosphate Synthetase. II. Biochemical and Genetic Aspects of the Pathway (Dissertation, University of North Carolina at Chapel Hill)
by Barry William Potvin (Author)

121 pages

Annals of the New York Academy of Sciences, Inflammatory Bowel Disease: Genetics, Barrier Function, and Immunological Mechanisms, and Microbial Pathways (Volume 1072)

Annals of the New York Academy of Sciences, Inflammatory Bowel Disease: Genetics, Barrier Function, and Immunological Mechanisms, and Microbial Pathways (Volume 1072)
by Wolfram W. Domschke (Editor), Martin F Kagnoff (Editor), Torsten F. Kucharzik (Editor), Lloyd Mayer (Editor), Stephan R. Targan (Editor)

Inflammatory bowel disease (IBD), which encompasses both Crohn's disease and ulcerative colitis, is a chronically relapsing intestinal disorder that is characterized by diarrhea and abdominal pain.

The incidence of IBD is increasing worldwide. Although some major advances have been made in recent years, the pathogenesis of the disease still remains obscure. As currently understood, a combination of genetic alterations and immunological disturbances causing an interaction of the enteric microflora with the underlying mucosa and a disrupted barrier function may be crucial for the development of disease.

Despite substantial new data that have been obtained over the last several years, it has become increasingly difficult to accommodate these into a unifying...

Signalling Pathways in Apoptosis (Modern Genetics , Vol 5)

Signalling Pathways in Apoptosis (Modern Genetics , Vol 5)
by Diane Watters (Author), Martin Lavin (Author)

Apoptosis, or programmed cell death, is a necessary process by which a cell may die without adversely affecting its environment. It plays a crucial role in normal development, and in the body's defence mechanisms against disease. Too much cell death is destructive, leading to neurodegenerative diseases and impaired development. Conversely, too little cell death can lead to an increased susceptibility to cancer and sustained viral infection. Apoptosis is a matter of balance-a balance which is sustained or offset by various signaling pathways within the cell.
Dramatic progress has been made in the study of apoptosis over the past decade. One of the most rapidly expanding knowledge bases being established is on the molecular mechanisms controlled by a variety of gene products including...

© 2009 BrightSurf.com